TCS 3,497.15 -55.50 (-1.56%) 
HDFCBANK 1,743.85 +10.70 (0.62%) HINDUNILVR 2,200.80 -0.85 (-0.04%) INFY 1,586.55 -22.25 (-1.38%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,636.65 +8.50 (0.52%) KOTAKBANK 2,021.45 -13.15 (-0.65%) ICICIBANK 1,312.70 +3.10 (0.24%) ITC 403.05 -6.35 (-1.55%) BAJFINANCE 8,737.15 +57.40 (0.66%) MARUTI 11,621.05 -99.15 (-0.85%) HCLTECH 1,543.50 -15.00 (-0.96%) SBIN 745.05 +8.00 (1.09%) NESTLEIND 2,184.75 -17.70 (-0.80%) ASIANPAINT 2,279.90 +6.30 (0.28%) WIPRO 265.75 +4.35 (1.66%) DMART 3,845.55 +13.60 (0.35%) AXISBANK 1,052.20 +6.60 (0.63%) LT 3,318.80 +47.75 (1.46%) HDFCLIFE 664.50 +23.75 (3.71%) SUNPHARMA 1,733.45 -15.15 (-0.87%) ULTRACEMCO 10,934.70 +235.25 (2.20%) ONGC 232.60 +0.50 (0.22%) BAJAJFINSV 1,841.70 -3.30 (-0.18%) BPCL 265.35 +3.20 (1.22%) POWERGRID 276.95 +6.15 (2.27%) TITAN 3,075.35 -7.40 (-0.24%) BRITANNIA 4,720.00 -51.25 (-1.07%) NTPC 341.20 +3.80 (1.13%) Download Unicorn Signals App
By EquityPandit
Aurobindo Pharma has got the final approval from the US health regulator for generic version of an intravenous antidote to a pain killer drug overdose.
It said in a BSE filing that “The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Acetylcysteine Injection, 6g/30 mL (200 mg/mL) single-dose vials.”
The product is likely to be launched in the first quarter of the next fiscal.
